Fluorescence PCR · Respiratory Infections
Six Respiratory Pathogens Nucleic Acid Detection Kit (Fluorescence PCR)
Qualitative detection of respiratory syncytial virus, adenovirus, human metapneumovirus, rhinovirus, parainfluenza virus types I/II/III, and Mycoplasma pneumoniae nucleic acids in oropharyngeal swabs to aid in diagnosis of respiratory infections.
- SKU Code
AENE-RT175- Approval
- On request
- Product Type
- Assay / Kit
- Status
- Available
Qualitative detection of respiratory syncytial virus, adenovirus, human metapneumovirus, rhinovirus, parainfluenza virus types I/II/III, and Mycoplasma pneumoniae nucleic acids in oropharyngeal swabs to aid in diagnosis of respiratory infections.
| Product type | Assay / Kit |
|---|---|
| Technology platform | Fluorescence PCR |
| Application area | Respiratory Infections |
Epidemiology
Respiratory tract infections are the most prevalent human diseases, affecting all sexes, ages, and regions, and represent a major global cause of illness and death. Frequently encountered clinical respiratory pathogens include respiratory syncytial virus, adenovirus, human metapneumovirus, rhinovirus, parainfluenza virus types I, II, and III, and Mycoplasma pneumoniae. Although the clinical presentation of respiratory infections is often similar, the specific pathogen determines differences in management, effectiveness, and illness duration. Current laboratory detection approaches for these pathogens encompass viral isolation, antigen testing, and nucleic acid amplification. By detecting and identifying specific viral nucleic acids from symptomatic patients, this kit supports the diagnosis of respiratory viral infections when interpreted alongside other clinical and laboratory data.
Work Flow
A general DNA/RNA extraction kit, which can be paired with an automated nucleic acid extractor, is suggested for sample preparation. All following procedures must be carried out exactly as described in the kit's instructions for use.
| SKU code | AENE-RT175 |
|---|---|
| Storage | ≤-18℃ |
| Shelf-life | 12 months |
| Specimen Type | Oropharyngeal swab sample |
| Ct | Adv, PIV, MP, RhV, hMPV, RSV Ct≤38 |
| CV | 5.0% |
| LoD | LoD of Adv, MP, RSV, hMPV, RhV and PIV are all 200Copies/mL |
| Specificity | The results of the cross-reactivity test showed that there is no cross-reactivity between the kit and novel coronavirus, influenza A virus, influenza B virus, human bocavirus, cytomegalovirus, herpes simplex virus type 1, varicella zoster virus, EBV, pertussis bacillus, Chlamydophila pneumoniae, Corynebacterium spp, Escherichia coli, Haemophilus influenzae, Lactobacillus spp, Legionella pneumophila, C. catarrhalis, and attenuated strains of Mycobacterium tuberculosis, Neisseria meningitidis, Neisseria spp, Pseudomonas aeruginosa, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus salivarius, Actinobacillus baumannii, Narrow-feeding maltophilic monococci, Burkholderia maltophilia, Streptococcus striatus, Nocardia sp. Sarcophaga viscosa, Citrobacter citriodora, Cryptococcus spp, Aspergillus fumigatus, Aspergillus flavus, Pneumatobacteria spp, Candida albicans, Rohypnogonia viscera, oral streptococci, Klebsiella pneumoniae, Chlamydia psittaci, Rickettsia q fever and human genomic nucleic acids. Anti-interfering ability: mucin (60 mg/mL), human blood, benfotiamine (2 mg/mL), oxymetazoline (2 mg/mL), sodium chloride (20 mg/mL), beclomethasone (20 mg/mL), dexamethasone (20 mg/mL), flunitrazolone (20 μg/mL), triamcinolone acetonide (2 mg/mL), budesonide (1 mg/ mL), mometasone (2 mg/mL), fluticasone (2 mg/mL), histamine hydrochloride (5 mg/mL), intranasal live influenza virus vaccine, benzocaine (10%), menthol (10%), za |
| Applicable Instruments | SLAN-96P Real-Time PCR Systems Applied Biosystems 7500 Real-Time PCR System QuantStudio ® 5 Real-Time PCR Systems LineGene 9600 Plus Real-Time PCR Detection System MA-6000 Real-Time Quantitative Thermal Cycler BioRad CFX96 Real-Time PCR System BioRad CFX Opus 96 Real-Time PCR System |
| Approval | On request |
|---|---|
| Documents | Datasheet, IFU, SDS, COA / conformance, origin, and export documents where available |
FAQ
What should be confirmed before quotation?
Sample context, collection method, and extraction workflow should be confirmed before final kit selection.
Which documents can be requested?
Datasheet, IFU, SDS, COA / conformance, origin, insurance, and export documents can be checked where available.
Can the format be adjusted for different workflows?
Liquid or lyophilized format options should be confirmed together with instrument compatibility and shipment requirements.
Inquiry
Send the essentials for a useful first reply.
Share the application, sample type, format, destination, and expected quantity so AeneBio can route AENE-RT175 to the right quote or sample discussion.